Stock Price
17.04
Daily Change
0.17 1.01%
Monthly
5.77%
Yearly
-11.16%
Q3 Forecast
15.77

EPS Reference Time Actual Consensus Previous
2026-10-23 FY2026Q3 AM 0.30 0.19
2026-08-28 FY2026Q1 AM 0.49 0.84
2026-03-31 FY2026Q1 AM 0.16 0.19 0.13
2025-10-30 FY2025Q3 AM 0.19 0.32 0.30
2025-08-28 FY2025Q1 AM 0.84 0.41 0.38



Peers Price Chg Day Year Date
Cspc Pharmaceutical 8.60 0.17 2.02% -4.02% Jul/16
Sino Biopharmaceutical 5.26 0.03 0.57% -22.87% Jul/16
Sh Fosun Pharma 24.71 -0.13 -0.52% -6.40% Jul/16
Jiangsu Hengrui 55.99 -1.51 -2.63% -3.01% Jul/16
WuXi AppTec 127.00 -4.50 -3.42% 56.75% Jul/16

Indexes Price Day Year Date
SHANGHAI 3882 -73.17 -1.85% 10.40% Jul/16

Sh Pharmaceutical traded at 17.04 this Thursday July 16th, increasing 0.17 or 1.01 percent since the previous trading session. Looking back, over the last four weeks, Sh Pharmaceutical gained 5.77 percent. Over the last 12 months, its price fell by 11.16 percent. Looking ahead, we forecast Sh Pharmaceutical to be priced at 15.77 by the end of this quarter and at 14.73 in one year, according to Trading Economics global macro models projections and analysts expectations.

Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The Company distributes its products both in the domestic market and to overseas markets.